[Ip-health] The Biosimilars Conference at the University of Washington

[Joana Ramos]

Here's the meeting notice & conference website link.

Joana
-----------------------------
http://depts.washington.edu/uwconf/biosimilars/index.php


The Biosimilars Conference at the University of Washington
designed for Professionals in the Pharmaceutical and Biotech Industries

March 19-20, 2010
University of Washington

The expiration of patents on therapeutic biological products raises
major technological and policy questions about potential "generic"
quivalents =96 so-called biosimilar or follow-on biologics. While there
may be great opportunities for manufacturers and professionals in the
biosimilars field, parallel concerns regarding manufacturing, clinical
trials, economics, intellectual property, analytical methods, safety and
efficacy arise. T he UW Conference on Biosimilars will provide updates
and explore potential solutions to these concern.

Respected faculty from the University of Washington and research and
business professionals from local biomedical companies will lead you
through the state of biosimilars. Participants at the conclusion of the
conference will be able to:

* Explain the current availability and impact of biosimilars in Latin
America
* Compare and contrast the intellectual property issues between pioneers
and generics
* Analyze the FDA's current view of biosimilars
* Explain the economics of biosimilars through case examples.
* Determine issues surrounding biosimiliars and clinical trials.

Who should attend?

The program is designed to serve the needs of professionals in the
pharmaceutical and biotech industries who work on clinical development,
process development, safety and quality assurance, regulatory
compliance, legal affairs and corporate strategic planning. College
students who interested in advancing their knowledge about biosimilars
are encouraged to attend.
Why should you attend?

* Connect with other professionals in the field
* Acquire pertinent resources
* Prepare for the future of biosimilars in the market

Fees:

$465 before March 1
$555 starting March 2

$310 at all times for UW faculty members, staff and students.


-----------------------
Joana Ramos, MSW
Cancer Resources & Advocacy
Seattle WA USA
+1-206-229-2420
http://ramoslink.info/
www.bmtbasics.org